-transparent.png){kind=logo}
DNA methyltransferases (DNMTs) are highly conserved DNA-modifying enzymes that play important roles in epigenetic regulation and they are involved in cell proliferation, differentiation, and apoptosis. In mammalian cells, three active DNMTs have been identified: DNMT1 acts as a maintenance methyltransferase to replicate preexisting methylation patterns, whereas DNMT3A and DNMT3B primarily act as de novo methyltransferases that are responsible for establishing DNA methylation patterns by adding a methyl group to cytosine bases. The expression of DNMT3B is widespread in a variety of hematological cells and it is altered in each type of leukemia, which is associated with its pathogenesis, progression, treatment, and prognosis. Here, we review current information on DNMT3B in leukemia, including its expression, single-nucleotide polymorphisms, mutations, regulation, function, and clinical value for anti-leukemic therapy and prognosis.
Haibin Zhang, and
Houqun Ying, and
Xiaozhong Wang
January 2012,
PloS one,
Haibin Zhang, and
Houqun Ying, and
Xiaozhong Wang
August 2002,
The Journal of biological chemistry,
Haibin Zhang, and
Houqun Ying, and
Xiaozhong Wang
November 2020,
Nucleic acids research,
Haibin Zhang, and
Houqun Ying, and
Xiaozhong Wang
November 2010,
The Journal of biological chemistry,
Haibin Zhang, and
Houqun Ying, and
Xiaozhong Wang
December 1999,
Proceedings of the National Academy of Sciences of the United States of America,
Haibin Zhang, and
Houqun Ying, and
Xiaozhong Wang
December 2002,
Protein engineering,
Haibin Zhang, and
Houqun Ying, and
Xiaozhong Wang
July 2014,
Leukemia,
Haibin Zhang, and
Houqun Ying, and
Xiaozhong Wang
May 2006,
Human molecular genetics,
Haibin Zhang, and
Houqun Ying, and
Xiaozhong Wang
December 2016,
Leukemia,
Haibin Zhang, and
Houqun Ying, and
Xiaozhong Wang
January 2016,
eLife,
